Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal J Meropol

Showing results (51-60 of 226) with videos related to

Pageof 23
Sort By:
Clinical Colorectal Cancer|August 16, 2005
Changing patterns of bone and brain metastases in patients with colorectal cancerMark L Sundermeyer, Neal J Meropol, Andre Rogatko, et al.
The Lancet. Oncology|October 14, 2003
Amifostine and chemoradiation therapy: ASCO respondsLynn Schuchter, Neal J Meropol, Eric P Winer, et al.
The Oncologist|May 25, 2010
Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choicesYu-Ning Wong, Olivia Hamilton, Brian Egleston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Patients' decision-making process regarding participation in phase I oncology researchManish Agrawal, Christine Grady, Diane L Fairclough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Centralization of cancer surgery: implications for patient access to optimal careKaryn B Stitzenberg, Elin R Sigurdson, Brian L Egleston, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2011
Decision tree-based modeling of androgen pathway genes and prostate cancer riskJill S Barnholtz-Sloan, Xiaowei Guan, Charnita Zeigler-Johnson, et al.
Cancer|March 25, 2009
Cost implications of new treatments for advanced colorectal cancerYu-Ning Wong, Neal J Meropol, William Speier, et al.
Journal of Oncology Practice|July 24, 2014
Oncologists' response to new data regarding the use of epidermal growth factor receptor inhibitors in colorectal cancerEfrat Dotan, Tianyu Li, Michael J Hall, et al.
Oncology|July 16, 2005
A phase I study of docetaxel, Cisplatin, 5-Fluorouracil and leucovorinMary F Mulcahy, Patrick J Loehrer, Neal J Meropol, et al.
Cancer Chemotherapy and Pharmacology|December 22, 2015
A pharmacokinetic analysis of cisplatin and 5-fluorouracil in a patient with esophageal cancer on peritoneal dialysisJennifer R Eads, Jan H Beumer, Lavinia Negrea, et al.
Pageof 23

Showing results (51-60 of 226) with videos related to

Sort By:
Pageof 23
Clinical Colorectal Cancer|August 16, 2005
Changing patterns of bone and brain metastases in patients with colorectal cancerMark L Sundermeyer, Neal J Meropol, Andre Rogatko, et al.
The Lancet. Oncology|October 14, 2003
Amifostine and chemoradiation therapy: ASCO respondsLynn Schuchter, Neal J Meropol, Eric P Winer, et al.
The Oncologist|May 25, 2010
Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choicesYu-Ning Wong, Olivia Hamilton, Brian Egleston, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Patients' decision-making process regarding participation in phase I oncology researchManish Agrawal, Christine Grady, Diane L Fairclough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Centralization of cancer surgery: implications for patient access to optimal careKaryn B Stitzenberg, Elin R Sigurdson, Brian L Egleston, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 16, 2011
Decision tree-based modeling of androgen pathway genes and prostate cancer riskJill S Barnholtz-Sloan, Xiaowei Guan, Charnita Zeigler-Johnson, et al.
Cancer|March 25, 2009
Cost implications of new treatments for advanced colorectal cancerYu-Ning Wong, Neal J Meropol, William Speier, et al.
Journal of Oncology Practice|July 24, 2014
Oncologists' response to new data regarding the use of epidermal growth factor receptor inhibitors in colorectal cancerEfrat Dotan, Tianyu Li, Michael J Hall, et al.
Oncology|July 16, 2005
A phase I study of docetaxel, Cisplatin, 5-Fluorouracil and leucovorinMary F Mulcahy, Patrick J Loehrer, Neal J Meropol, et al.
Cancer Chemotherapy and Pharmacology|December 22, 2015
A pharmacokinetic analysis of cisplatin and 5-fluorouracil in a patient with esophageal cancer on peritoneal dialysisJennifer R Eads, Jan H Beumer, Lavinia Negrea, et al.
Pageof 23